Tradestie Institutional Equity Comparison Engine

KZR vs AVDL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-05-08 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AVDL Overall Edge

AVDL Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avadel Pharmaceuticals plc Ordinary Share (AVDL) driven by superior Valuation, Growth & Margin, Momentum & Technical while KZR counters with relative strength in Options & Structure. Fundamentally, KZR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus AVDL at 28.8x Forward P/E and 2.5% operating margin (+54.9% YoY). In options structure, KZR sits in UNCLASSIFIED (9th %ile IV; Dealer Gamma Walls on Pro) against AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AVDL
KZR N/M vs AVDL 28.8x Fwd P/E
Growth & Margin Winner AVDL
Op Margin 0.0% vs 2.5% ยท YoY +0.0% vs +54.9%
Momentum & Technical Winner AVDL
1Y +78.7% vs +138.1% ยท 52W Pos 94% vs 89%
Options & Structure Winner KZR
UNCLASSIFIED (9th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
KZR NASDAQ
Kezar Life Sciences, Inc. Common Stock
Pharmaceutical Preparations
$7.29
-0.95% 1D
Market Cap $54.4M
1M Return -0.82%
1Y Return +78.68%
Forward P/E N/M
Unified AI Score
60.1 / 100 BUY
Tech 40.0 Fund 51.0 Flow 56.0 Mom 58.1
AVDL NASDAQ
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap $2.1B
1M Return +0.65%
1Y Return +138.06%
Forward P/E 28.8x
Unified AI Score
62.9 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: KZR +78.68% AVDL +138.06% Spread: +73.12 pp (AVDL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
KZR TTM Op. Margin: 0.0% AVDL TTM Op. Margin: 2.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KZR vs AVDL. Trailing 12-month operating profitability (KZR 0.0% vs AVDL 2.5%) and valuation multiples (KZR N/M vs AVDL 28.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: KZR (1) vs AVDL (8)
Institutional Metric KZR AVDL Criterion Row Winner
Market Capitalization Scale $54.4M $2.1B Larger Scale AVDL
Trailing P/E Ratio Valuation N/M 16.8x Lower Multiple AVDL
Forward P/E Ratio Valuation N/M 28.8x Lower Multiple AVDL
Revenue Growth (YoY) Growth +0.0% +54.9% Higher Growth AVDL
Operating Margin (TTM) Profitability 0.0% 2.5% Higher Margin AVDL
Net Profit Margin Profitability 0.0% -0.1% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -59.9% -0.3% Higher ROE AVDL
52-Week Range Position Momentum 94% ($4โ€“$8) 89% ($6โ€“$24) Stronger Trend KZR
Beta / 30D Volatility Risk Regime 0.60ฮฒ ยท 8% Vol 0.14ฮฒ ยท 2% Vol Lower Realized Risk AVDL
Unified Institutional Score Composite Signal 60.1 / 100 (BUY) 62.9 / 100 (BUY) Higher Composite AVDL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full KZR vs AVDL Buy Guide
KZR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live KZR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AVDL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live AVDL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither KZR nor AVDL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.